APEN stock forecast
Our latest prediction for Apollo Endosurgery, Inc.'s stock price was made on the Dec. 27, 2018 when the stock price was at 3.24$.
In the short term (2weeks), APEN's stock price should underperform the market by -0.10%. During that period the price should oscillate between -11.46% and +18.53%.
In the medium term (3months), APEN's stock price should outperform the market by 5.53%. During that period the price should oscillate between -21.50% and +45.88%.Get email alerts
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company, which engages in the design, development, and commercialization of medical devices. It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.
At the moment the company generates 57M USD in revenues.
On its last earning announcement, the company reported a loss of -1.84$ per share.
The book value per share is 2.52$
Three months stock forecastDec. 27, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|